Penumbra Coil 400 4002C0312Recalls & reported problems
Penumbra, Inc. · PC400 Cplx Std, 3x12 · Class 2
All models of Penumbra Coil 400 (120)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI M4244002C03120), received between Oct 5, 2017 and Jun 22, 2018 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Physical Resistance” (4 reports).
1 other recall cover devices cleared under the same FDA submission (K103305); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Physical Resistance4
- Failure to Advance3
- Mechanical Jam1
Patient problems
- No Consequences Or Impact To Patient4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 22, 2018Failure to Advance; Physical Resistance; Failure to Advance; Physical Resistance
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE USING PENUMBRA COIL 400S (PC400S). DURING THE PROCEDURE, THE PHYSICIAN FELT RESISTANCE AND WAS UNABLE TO ADVANCE A PC400 OUT OF THE TIP OF THE INTRODUCER SHEATH AND INTO THE HUB OF A LANTERN DELIVERY MICROCATHETER (LANTERN), DESPITE ATTEMPTING MULTIPLE TIMES. THE PHYSICIAN REMOVED THE PC400 AND ATTEMPTED TO ADVANCE IT OUT OF THE INTRODUCER SHEATH ON THE BACK TABLE, HOWEVER WAS UNABLE TO DESPITE ATTEMPTING MULTIPLE TIMES AND FLUSHING THE PC400. THE PROCEDURE WAS THEREFORE COMPLETED USING A NEW PC400 AND THE SAME LANTERN. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7631738 ↗MalfunctionJan 3, 2018Failure to Advance; Physical Resistance; Failure to Advance; Physical Resistance
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE INFERIOR MESENTERIC ARTERY (IMA) USING PENUMBRA COIL 400S (PC400S). DURING THE PROCEDURE, THE PHYSICIAN EXPERIENCED RESISTANCE AND WAS UNABLE TO ADVANCE A PC400 OUT OF ITS INTRODUCER SHEATH AND INTO THE LANTERN DELIVERY MICROCATHETER (LANTERN), AND THEREFORE THE PC400 WAS REMOVED. THE PROCEDURE WAS THEN COMPLETED USING 6 ADDITIONAL PC400S AND THE SAME LANTERN. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7163086 ↗MalfunctionDec 27, 2017Physical Resistance; Mechanical Jam; Physical Resistance; Mechanical Jam
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE LEFT INTERNAL ILIAC ARTERY (IIA) TO TREAT TYPE II ENDOLEAK USING PENUMBRA COILS 400 (PC400S). IT WAS REPORTED THAT THE PATIENT ANATOMY WAS MILDLY TORTUOUS. DURING THE PROCEDURE, THE PHYSICIAN PLACED TWO NON-PENUMBRA COILS AND ONE PC400 IN THE TARGET VESSEL USING A NON-PENUMBRA MICROCATHETER. WHILE ATTEMPTING TO ADVANCE A NEW PC400 THROUGH THE MICROCATHETER, THE PHYSICIAN EXPERIENCED RESISTANCE RIGHT AFTER INSERTING THE PC400 INTO THE MICROCATHETER AND THE PC400 BECAME STUCK; THEREFORE IT WAS REMOVED. THE PROCEDURE WAS COMPLETED USING ANOTHER COIL AND THE SAME MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7149453 ↗MalfunctionOct 5, 2017Failure to Advance; Physical Resistance; Failure to Advance; Physical Resistance
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE RIGHT HEPATIC ARTERY USING PENUMBRA COIL 400S (PC400S). DURING THE PROCEDURE, THE PHYSICIAN FELT RESISTANCE AND WAS UNABLE TO ADVANCE A PC400 THROUGH THE HUB OF A NON-PENUMBRA MICROCATHETER; THEREFORE, THE PC400 WAS REMOVED. THE PHYSICIAN THEN SUCCESSFULLY PLACED TWO NON-PENUMBRA COILS USING THE MICROCATHETER. THE PHYSICIAN ATTEMPTED TO ADVANCE A NEW PC400, HOWEVER AGAIN FELT RESISTANCE AND WAS UNABLE TO ADVANCE THROUGH THE HUB OF THE MICROCATHETER. THE PHYSICIAN THEREFORE REMOVED THE PC400 AND MICROCATHETER, AND FLUSHED THE MICROCATHETER. THE PHYSICIAN THEN REINSERTED THE SAME MICROCATHETER AND RE-ATTEMPTED TO ADVANCE THE TWO PC400S, BUT WAS STILL UNABLE TO. THE PROCEDURE WAS THEREFORE COMPLETED USING THE SAME MICROCATHETER, NEW PC400S, AND ADDITIONAL COILS. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6918001 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K103305. One submission often covers many models, so check the product and lot details in each record.
- Z-1906-2011 · Mar 4, 2011 · TerminatedPenumbra brand Penumbra Coil System, Penumbra Coil 400, Product is manufactured and distributed by Penumbra Inc., Alameda, CA The Penumbra Coil System (Penumbra Coil 400 TM) is in
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page